These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 3972233

  • 21. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
    Stewart CA, Termanini B, Sutliff VE, Serrano J, Yu F, Gibril F, Jensen RT.
    Aliment Pharmacol Ther; 1998 Jan; 12(1):83-98. PubMed ID: 9692706
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R, Amantea MA, Maton PN, Frucht H, Gardner JD, Jensen RT.
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [Abstract] [Full Text] [Related]

  • 23. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
    Ramdani A, Mignon M, Samoyeau R.
    Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
    [Abstract] [Full Text] [Related]

  • 24. Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery.
    Vinayek R, Frucht H, London JF, Miller LS, Stark HA, Norton JA, Cederberg C, Jensen RT, Gardner JD, Maton PN.
    Gastroenterology; 1990 Jul; 99(1):10-6. PubMed ID: 1971604
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
    Bardram L, Stadil F.
    Scand J Gastroenterol Suppl; 1989 Jul; 166():95-100; discussion 111-3. PubMed ID: 2574912
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Gastric secretory, ultrastructural and pH changes during prolonged treatment with omeprazole in a severe form of Zollinger-Ellison syndrome].
    Mignon M, Alcabes G, Lehy T, Nguyen Phuoc BK, Vatier J, Bonfils S.
    Gastroenterol Clin Biol; 1984 Dec; 8(12):947-54. PubMed ID: 6519403
    [Abstract] [Full Text] [Related]

  • 30. Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome.
    Désir B, Poitras P.
    Can J Gastroenterol; 2001 Dec; 15(12):795-8. PubMed ID: 11773945
    [Abstract] [Full Text] [Related]

  • 31. Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori, and proton pump inhibitor therapy.
    Weber HC, Venzon DJ, Jensen RT, Metz DC.
    Gastroenterology; 1997 Jan; 112(1):84-91. PubMed ID: 8978346
    [Abstract] [Full Text] [Related]

  • 32. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M, Hochlaf S, Forestier S, Ruszniewski P, Vatier J, Joubert-Collin M.
    Gastroenterol Clin Biol; 1994 Jan; 18(1):13-6. PubMed ID: 8187984
    [Abstract] [Full Text] [Related]

  • 33. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.
    Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT.
    Am J Med; 1998 May; 104(5):422-30. PubMed ID: 9626024
    [Abstract] [Full Text] [Related]

  • 34. [Omeprazole, the drug of the future for the treatment of Zollinger-Ellison syndrome and duodenal ulcer?].
    Fiasse R, Tomé G, Dive C.
    Acta Gastroenterol Belg; 1984 May; 47(6):555-68. PubMed ID: 6537111
    [No Abstract] [Full Text] [Related]

  • 35. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 May; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 36. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
    Maton PN, Lack EE, Collen MJ, Cornelius MJ, David E, Gardner JD, Jensen RT.
    Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
    [Abstract] [Full Text] [Related]

  • 37. Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high.
    Metz DC, Pisegna JR, Fishbeyn VA, Benya RV, Feigenbaum KM, Koviack PD, Jensen RT.
    Gastroenterology; 1992 Nov; 103(5):1498-508. PubMed ID: 1426868
    [Abstract] [Full Text] [Related]

  • 38. Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.
    McArthur KE, Raufman JP, Seaman JJ, Ziemniak JA, Gardner JD, Jensen RT.
    Gastroenterology; 1987 Jul; 93(1):69-76. PubMed ID: 3582917
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
    Maton PN, Frucht H, Vinayek R, Wank SA, Gardner JD, Jensen RT.
    Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.